Sanofi India Limited (SANOFI) — Announcement
· NSE
🔴 High Importance
Neutral
No summary available
About Sanofi India Limited (SANOFI)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
Market Cap: ₹7,411.02 Cr
P/E: 17.9
📡 Get AI alerts when SANOFI files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track SANOFI — Free💡 Ask AI about this filing
"How does this announcement affect Sanofi India Limited's outlook?"
"What did Sanofi India Limited announce on 15 June 2026?"
"Is this positive or negative for SANOFI?"
Ask AI Free →
📊 More SANOFI filings
- share transfer — 7 July 2026 Sanofi India Limited received a SEBI-mandated share transfer agent certificate confirming dematerial...
- Financial Results — 26 June 2026 Sanofi India Limited announced that its trading window will close on 1st July 2026 for the unaudited...
- Announcement — 24 June 2026 Sanofi India disclosed a GST refund rejection for the 2014-15 to 2017-18 period amounting to INR **1...
- Announcement — 9 June 2026 Sanofi India received a favorable CGST order dropping a tax demand of INR 10.57 lakhs with interest ...
- 🟡 Board Meeting — 3 June 2026 Sanofi India announced the appointment of Debajit Roy as Sales & Customer Engagement Head – Diabetes...
🔥 Also filed on 15 June 2026
PRIMO
Primo Chemicals Limited
Announcement
RACLGEAR
RACL Geartech Limited
Insider Trading
PUNJLLOYD
Punj Lloyd Limited
Announcement
RAYMONDREL
Raymond Realty Limited
Announcement
RBLBANK
RBL Bank Limited
Insider Trading
RELCHEMQ
Reliance Chemotex Industries Limited
Corporate Action
View all today's announcements →
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
📡 Get AI alerts when SANOFI files new disclosures
Track SANOFI filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track SANOFI — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research